dihexa human clinical trials status in Trials: What We've Learned So Far Dihexa Peptide: Unlocking Brain Repair,

It is banned in competition by the World Anti-Doping Agency (WADA) It is not classified as a controlled substance, making personal possession legal in most regions It is not allowed to be marketed for human consumption, meaning capsules often operate in a legal gray area Sourcing Quality and Contamination Risks Because BPC157 isnt regulated, product quality can vary dramatically

Sterile tools support safe injection preparation for patients

modest increases in prolactin and cortisol levels 1

Cagrilintide monotherapy remains investigational, and the CagriSema combination although it has been submitted for regulatory review remained unapproved as of this writing

doi:10.1371/journal.pone.0263971